It is the only medical device company to make it to the list and ranked 275th position among India’s top 500 firms
Molbio Diagnostics, in-vitro diagnostics company and inventor of the Truenat technology, has been awarded the certificate of recognition among the 500 most valuable companies. It is the only medical device company to make it to the list and ranked 275th position among India’s top 500 firms.
The Burgundy Private Huron 2022 is the second edition of the list that ranks the country’s 500 most valuable organizations, according to their market valuations. The list is published by Burgundy Private, Axis Bank’s Private Banking Business, and Hurun India.
Molbio Diagnostics recently became Goa’s first and only unicorn after receiving an investment of $85 million from Singapore-based investment company, Temasek. As part of its growth plans, the company is intending to rapidly expand into the US and European markets.
Commenting on the achievement, Sriram Natarajan, Founder, Director & CEO, Molbio Diagnostics said, “We are honoured to be recognised under the list of the 500 most valuable companies. We are continuously striving to fulfil Molbio’s aim and goal of becoming the answer to innovation and introducing new technology for social advancement and transforming Indian healthcare practises by providing near-care diagnostic solutions.”
Also commenting on the achievement, Dr Chandrasekhar Nair, Co-Founder & CTO, Molbio Diagnostics said, It’s always encouraging to see Molbio achieve success and receive recognition from the industry players. It inspires us to work hard and create solutions that can make a difference in the future. Molbio’s goal is to provide the world with affordable, portable, all-encompassing diagnostic tools and technologies that can be used at the point of care with minimal access.”